Stock-Based Compensation (Tables)

6 Months Ended

Jul. 29, 2017

Stock-based compensation expense by type

The compensation costs that have been charged against income for the thirteen and twenty-six weeks ended July 29, 2017 and July 30, 2016 were as follows (in thousands):

	Thirteen Weeks Ended				Twenty-Six Weeks Ended
	July 29, 2017		July 30, 2016		July 29, 2017		July 30, 2016
Stock-based compensation expense by type:
Stock options	$	-	$	3	$	172	$	384
Restricted stock unit awards, including performance-based		618		898		2,109		2,607
Employee stock purchases		23		22		56		58
Director deferred compensation		6		24		12		47
Total stock-based compensation expense		647		947		2,349		3,096
Income tax benefit recognized		228		344		844		1,125
Stock-based compensation expense, net of income tax	$	419	$	603	$	1,505	$	1,971

Equity awards granted during the period

In the thirteen and twenty-six weeks ended July 29, 2017 and July 30, 2016, we granted the following equity awards:

	Thirteen Weeks Ended				Twenty-Six Weeks Ended
	July 29, 2017		July 30, 2016		July 29, 2017		July 30, 2016
Stock options		-		318		20,372		36,359
Restricted stock unit awards		-		-		108,429		100,775
Performance-based restricted stock unit awards		-		-		54,900		45,300
Deferred stock units		286		674		487		14,156

Employee Stock Purchases during the period

Our employee purchases of common stock, the average price per share and the weighted-average grant date fair value of shares purchased through the our employee stock purchase plan were as follow:

	Thirteen Weeks Ended				Thirty-Nine Weeks Ended
	July 29, 2017		July 30, 2016		July 29, 2017		July 30, 2016
Shares purchased		5,281		3,021		10,745		8,638
Average price per share	$	17.64	$	29.57	$	21.42	$	27.05
Weighted average fair value at grant date	$	6.26	$	7.49	$	5.24	$	6.83